N-acetylcysteine has one role that is settled beyond dispute: given in hospital, it is the antidote for acetaminophen overdose and prevents most of the liver injury a large dose would otherwise cause. In chronic bronchitis and COPD it works as a mucolytic and modestly reduces flare-ups, and there is moderate evidence in a few psychiatric conditions such as trichotillomania.
Glycine, an amino acid the body makes but not always in plenty, has small trials for falling asleep faster. GlyNAC, glycine plus NAC together, restores glutathione and improves mitochondrial and aging markers in older adults; those results are encouraging, and they come from small trials, several of them single-group, so the longevity claim waits on larger independent replication.
Findings & Outcomes
What It Is
N-acetylcysteine, usually written NAC, is a slightly modified form of the amino acid cysteine, and cysteine is the amino acid the body most often runs short of when it builds glutathione, its main internal antioxidant. Glycine is a second amino acid, one the body makes for itself but not always in the amount its jobs require, which is why it is called conditionally essential. Glutathione is built from three amino acids, and cysteine and glycine are two of them, so supplying both is the reasoning behind pairing them. That pairing, glycine plus NAC, goes by the shorthand GlyNAC.
What It Does
The findings for NAC and glycine cover the full range of evidence. Strength is separate from endorsement: the firmest result here is an emergency hospital treatment, and that is no reason to take NAC every day. From firmest to most preliminary:
- The acetaminophen overdose antidote is settled beyond dispute, and it belongs in the hospital.
- The mucolytic use in COPD is long-standing and turns on the dose: a standard 600 mg once-daily dose did not slow the long decline in lung function, while the modest reduction in flare-ups comes at the higher 600 mg twice-daily dose.
- The psychiatric trials are newer and uneven: one positive result in adult trichotillomania that a later trial in children did not repeat, and a small pooled improvement in depression.
- Glycine for sleep rests on a few small studies.
- GlyNAC for aging is the frontier: the markers move in the right direction, but the strongest single study is a 16-week randomized trial in a small group, and most of the work comes from one research team, several of its trials with no control arm.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Liver
NAC prevents most serious liver injury given within 8 to 10 hours of an acetaminophen overdose
If someone takes a dangerous overdose of acetaminophen, the hospital gives N-acetylcysteine, and given in time it stops most of the liver damage the overdose would otherwise cause. This is the best-established thing NAC does, and it happens in a hospital.
Prescott's 1979 report established intravenous N-acetylcysteine as the treatment of choice for paracetamol (acetaminophen) poisoning, showing that when it was given early after overdose, severe liver damage and death were largely prevented compared with the outcomes seen before an effective antidote existed. The mechanism is direct: a toxic dose of acetaminophen depletes hepatic glutathione, leaving the reactive metabolite NAPQI to injure liver cells, and NAC supplies cysteine so the liver can rebuild glutathione and detoxify it. The antidote's effectiveness falls the longer treatment is delayed, which is why it is a time-critical emergency treatment rather than anything a supplement can substitute for.
Who this may not transfer to:Overdose treatment applies across sexes and has been standard clinical practice for decades in mixed populations.
This is an emergency hospital treatment at high, supervised doses, not a use for a daily supplement. A suspected overdose is a reason to contact emergency services or a poison center immediately. The supplement uses of NAC described elsewhere on this page are unrelated to this antidote role.
The study · 1
Prescott et al., Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning · Br Med J 1979;2(6198):1097-1100
Respiratory
NAC 600 mg twice daily cut COPD exacerbations about 22% over a year
In chronic lung diseases like COPD and chronic bronchitis, taking NAC regularly leads to somewhat fewer flare-ups over a year. The benefit is modest and shows up best at the higher dose of 600 mg twice a day.
The 2019 Cochrane review of mucolytic agents versus placebo in chronic bronchitis and COPD found that regular use reduced exacerbations and led to a small reduction in disability, though the effect size has narrowed as larger, more recent trials have been added. The PANTHEON randomized trial, in 1,006 Chinese patients with moderate-to-severe COPD, gave 600 mg of NAC twice daily or placebo for one year and found the annual exacerbation rate fell from 1.49 to 1.16 (rate ratio 0.78, 95% CI 0.67 to 0.90). The high-dose benefit is more consistent than the standard-dose result.
Who this may not transfer to:COPD trial populations are heavily male-weighted, PANTHEON included, so the effect is best documented in men and less precisely estimated in women.
This is a reason a clinician managing COPD or chronic bronchitis might add NAC, at 600 mg twice a day, as an adjunct to standard inhaled therapy rather than a replacement for it. It reduces flare-ups modestly; it is not a treatment that restores lung function.
The studies · 2
Poole et al., Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease (Cochrane review) · Cochrane Database Syst Rev 2019;5:CD001287
Zheng et al., Twice daily N-acetylcysteine 600 mg for exacerbations of COPD (PANTHEON) · Lancet Respir Med 2014;2(3):187-194
NAC 600 mg daily did not slow lung-function decline over three years
Taking a standard daily dose of NAC did not protect the lungs from getting weaker over the years in people with COPD. It did not preserve lung function, which was the main thing the trial set out to test.
BRONCUS randomized 523 patients with COPD to 600 mg of NAC daily or placebo for three years. The rate of decline in FEV1, the primary endpoint, did not differ between the groups, so a standard daily dose did not preserve lung function over time. A pre-specified subgroup analysis suggested fewer exacerbations in patients not taking inhaled corticosteroids, which pointed toward the exacerbation benefit later seen more clearly at higher doses, but the main lung-function result was a clear null.
Who this may not transfer to:The trial population was predominantly male, as COPD trials of this era generally were, so the null on lung-function decline is best documented in men.
This is the reason NAC is framed as an adjunct that may reduce flare-ups rather than as a treatment that changes the long-term course of COPD. Anyone hoping it will protect lung function over the years should know the trial that tested that found no such effect.
The study · 1
Decramer et al., Effects of N-acetylcysteine on outcomes in COPD (BRONCUS) · Lancet 2005;365(9470):1552-1560
Anxiety And Stress
NAC left 56% of adults with trichotillomania much improved versus 16% on placebo
In one good trial, adults who compulsively pull out their hair pulled less when taking NAC than when taking a placebo. The result held up in that trial, though a later trial in children did not find the same benefit.
Grant and colleagues randomized 50 adults with trichotillomania to N-acetylcysteine (dosed up to 2,400 mg a day) or placebo for 12 weeks. The NAC group had significantly greater reductions on hair-pulling severity scales, and 56% were rated much or very much improved compared with 16% on placebo. The proposed mechanism is the effect of NAC on glutamate signaling in brain circuits involved in compulsive behavior. A later double-blind trial of NAC for trichotillomania in children and adolescents did not separate from placebo, so the adult finding has not generalized cleanly across age groups.
Who this may not transfer to:The sample was predominantly women, consistent with the condition's distribution, and included men; the effect is best documented in women.
This is a reasonable option to discuss with a clinician for adult trichotillomania, where the evidence is a single positive controlled trial, alongside rather than instead of established behavioral approaches. The lack of a repeat effect in children means it should not be assumed to work at every age.
The study · 1
Grant et al., N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study · Arch Gen Psychiatry 2009;66(7):756-763
How it works
Cysteine plus glycine for two weeks restored older adults' glutathione toward youthful levels
Older people tend to be low in glutathione, the body's main internal antioxidant. Giving the two amino acids needed to build it, cysteine and glycine, brought their glutathione back up toward the levels seen in younger people.
Sekhar and colleagues compared glutathione status in older versus younger adults and found the older group had substantially lower red-cell glutathione and higher oxidative stress. Supplementing cysteine (delivered as N-acetylcysteine) and glycine for two weeks restored the rate of glutathione synthesis and its concentration to levels comparable with the young, and reduced oxidative-stress markers. This established the mechanistic rationale for the later GlyNAC trials: that the age-related fall in glutathione reflects a shortage of its precursors rather than a fixed loss of the capacity to make it.
Who this may not transfer to:The study used small mixed-sex groups and was not powered to compare the sexes, so the biochemical effect is not separately established in men and women.
This is the mechanism the GlyNAC longevity work is built on. It shows the precursors can restore a biochemical marker; whether restoring that marker produces clinical benefit is the separate question the outcome trials address, and those remain small.
The study · 1
Sekhar et al., Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation · Am J Clin Nutr 2011;94(3):847-853
Mood & stress
NAC gave a small improvement in depressive symptoms across five trials of 574 people
Across the trials that have tested it, adding NAC produced a small improvement in low mood. The effect is modest and it was mostly studied alongside standard treatment, not on its own.
Fernandes and colleagues pooled five randomized placebo-controlled trials (574 participants) of N-acetylcysteine in people with depressive symptoms, most of them as adjunctive treatment. NAC improved depressive symptoms and functionality significantly more than placebo, though the effect size was small and the trials were clinically varied in dose and population. The proposed basis is NAC's effects on glutathione, oxidative stress and glutamate, all of which have been implicated in mood disorders.
Who this may not transfer to:The pooled trials enrolled mixed-sex adult populations; the small benefit was measured across both sexes.
This is an emerging, adjunctive signal rather than a stand-alone treatment for depression. It is something to weigh with a clinician alongside established care, not a reason to defer or replace evidence-based treatment for low mood.
The study · 1
Fernandes et al., N-acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis · J Clin Psychiatry 2016;77(4):e457-e466
Longevity And Mortality
GlyNAC's longevity evidence is small, mostly single-group, and from one research team
The studies behind the GlyNAC longevity claims are small and mostly done by one team, and several had no comparison group. That is a normal early stage for a real finding, and it means bigger, independent trials are what will settle it.
The GlyNAC evidence base for aging is concentrated in a series of trials from Sekhar's group, summarized in their own review, spanning open-label pilots and a small randomized trial. The consistency of the findings across those studies is a point in their favor, and the concentration in one group, the small sample sizes, and the reliance on single-group designs are the reasons the field treats the longevity claim as promising rather than established. Larger, independently run, blinded trials in more diverse populations are the missing piece.
Who this may not transfer to:The underlying trials used small mixed-sex samples not powered for sex comparisons, so sex-specific effects are not established.
Read the GlyNAC longevity claims as a hypothesis with encouraging early support, not a proven result. This is the context to keep in mind before adopting the full protocol, and the reason to watch for independent trials.
The study · 1
Sekhar, GlyNAC Supplementation Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Aging Hallmarks, Metabolic Defects, Muscle Strength, Cognitive Decline, and Body Composition: Implications for Healthy Aging · J Nutr 2021;151(12):3606-3616
GlyNAC for 16 weeks raised glutathione and improved aging markers in a 24-person trial
Older adults who took glycine and NAC together for four months restored their glutathione and improved measures of their cells' energy production, inflammation and physical function. The results are encouraging and the trial was small.
Kumar and colleagues reported a 24-participant randomized trial in which older adults took GlyNAC or placebo for 16 weeks; the GlyNAC group improved glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function and multiple aging hallmarks. An earlier open-label pilot in older adults (with a comparison to young adults rather than a placebo arm) had reported the same broad pattern of improvements in glutathione, mitochondrial function, insulin resistance, endothelial function, genotoxicity, muscle strength and cognition. The mechanistic basis is the precursor-restoration effect established earlier: supplying cysteine and glycine rebuilds the glutathione that falls with age.
Who this may not transfer to:The GlyNAC trials enrolled small mixed-sex groups of older adults and were not powered to compare the sexes, so the effect is not separately established in men and women.
This is a promising early result and it is not yet a settled longevity intervention. The trials are small, single-center and largely from one group, so anyone considering the protocol should treat it as a frontier option to weigh with a clinician, and watch for the larger independent trials that would confirm or narrow the effect.
The studies · 2
Kumar et al., Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial · J Gerontol A Biol Sci Med Sci 2023;78(1):75-89
Kumar et al., GlyNAC supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial · Clin Transl Med 2021;11(3):e372
Sleep
Glycine 3 g before bed helped people fall asleep faster in small trials
Taking around 3 grams of glycine before bed helped people fall asleep a little faster and feel less tired and groggy the next day. The studies were small, so this is a gentle, early signal rather than a settled sleep aid.
A small single-blind crossover study by Bannai and colleagues in partially sleep-restricted healthy volunteers found that 3 g of glycine before bed reduced daytime sleepiness and fatigue and shortened reaction time on a psychomotor vigilance task the next day; the memory-recognition and arithmetic tasks did not differ from placebo. A companion review from the same group summarized earlier small trials in which 3 g of glycine at bedtime shortened sleep-onset latency and improved subjective sleep quality, and proposed a mechanism through a mild lowering of core body temperature via glycine's action at NMDA receptors. All of these studies are small and several come from the same research group.
Who this may not transfer to:The glycine daytime-performance data come from male participants only, so the next-day performance effects are not established in women.
Glycine at about 3 g before bed is cheap and generally well tolerated, so it is reasonable to try, while treating it as preliminary. Sleep-regularity habits and the better-studied options carry more weight for anyone with a persistent sleep problem.
The studies · 2
Bannai et al., The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers · Front Neurol 2012;3:61
Bannai & Kawai, New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep · J Pharmacol Sci 2012;118(2):145-148
How It Works
Anatomy of the Practice
1In the liver, against an overdose
A toxic dose of acetaminophen uses up the liver glutathione faster than it can be replaced, leaving a reactive by-product that damages cells. NAC delivers cysteine quickly, the body rebuilds glutathione, and the by-product is cleared. Given early enough this prevents most of the liver injury, which is why NAC is the antidote kept in every emergency department.
2In the airways
NAC loosens mucus, which is why it is called a mucolytic, and it raises glutathione in lung tissue that sits under constant oxidative load in chronic bronchitis and COPD. Over months this shows up as somewhat fewer flare-ups; day-to-day breathing changes little.
3In aging cells
Glutathione tends to fall with age, and mitochondria, the parts of the cell that turn fuel into energy, work less cleanly as it does. Supplying cysteine and glycine together raises glutathione back toward younger levels in older adults, and the mitochondrial and oxidative-stress markers move with it. Whether that adds up to a longer or healthier life is the open question the trials have not been large enough to answer.
The common factor in all of this is glutathione, the body's main internal antioxidant, built inside the cell from three amino acids. The amino acid that most often limits how much gets built is cysteine, and NAC is a reliable way to deliver it. That one fact explains uses that look unrelated: NAC rebuilds the glutathione an overdose strips from the liver, raises it in lung tissue under oxidative strain, and helps refill the supply that runs low with age. Glycine is the third amino acid in the molecule, and older adults can run low on it too, so cysteine alone may not rebuild the full supply.
The hospital use of NAC for acetaminophen overdose is a separate matter from any supplement. It is an emergency treatment given at high doses under supervision and timed against the poisoning. Everything else on this page, for mucus, mood, and aging, concerns ordinary supplement-scale use.
A supplement dose of NAC will not treat an acetaminophen overdose. A suspected overdose is a medical emergency: call emergency services or a poison center immediately.
Through glutathione and mitochondria, this page connects to the wider work on senolytics and other aging-focused approaches, and through glycine it connects to collagen, which is roughly a third glycine by weight.
How to Take Them
Ways to Do It
These are inexpensive, widely available supplements, and the sensible way in depends on what you want from them. Food and the free options come first; the combination protocol is the frontier option and belongs in a conversation with a clinician, especially if you take other medicines.
The body makes glutathione from ordinary protein. Sulfur-rich foods such as eggs, garlic, onions and cruciferous vegetables supply cysteine, and glycine is plentiful in the collagen-rich parts of meat, in bone broth and in gelatin. A diet with enough good protein covers most people without any supplement at all, which is the fair starting point.
Small trials used about 3 g of glycine taken before bed and found people fell asleep a little faster and felt less groggy the next day. It is cheap, tastes faintly sweet, and dissolves in water. The evidence is preliminary and the effect is gentle, so it is reasonable to try while the better-evidenced options do more; see the [sleep environment](/go/integrative/practice/sleep-environment) and [melatonin](/go/integrative/practice/melatonin) pages.
A common supplement dose is 600 to 1,200 mg a day, the range used for its mucolytic effect and in most of the psychiatric trials. If a clinician is managing a chest condition, the flare-up evidence sits with 600 mg twice a day. Take it with food if it unsettles your stomach.
The trials paired glycine and NAC dosed to body weight, which works out to several grams of each a day, a good deal more glycine than the sleep dose. This is the frontier option, built on small trials that still need replication, so it is best done with a clinician who can weigh it against your other medicines and watch how you respond.
Both are sold as inexpensive single-ingredient powders and capsules. There is no need for a proprietary blend or a premium longevity label; a plain product from a brand that publishes third-party testing does the same job. Powders let you match the gram-scale doses used in the trials more easily than capsules.
Go Deeper
- Senolytics: the other frontier of aging-focused supplements, with the same gap between an appealing mechanism and the size of trial that would settle it.
- Collagen: roughly a third glycine by weight, which is part of why glycine intake and collagen turn up in the same conversations.
- Asthma: where the inhaled form of acetylcysteine needs care, because nebulized NAC can irritate the airways and trigger bronchospasm in some people.
The Chinese Medicine View
Glutathione, cysteine and glycine are modern biochemistry. They were isolated and understood in the twentieth century, they have no entry in the classical Chinese pharmacopoeia, no channel, flavor or temperature assigned by any historical text, and it would be an invention to claim the tradition anticipated them. What can be offered is a loose placement, held apart from the molecules themselves and from the trial data above.
Two areas come close, and neither is a match. The first is the lung. Chinese medicine reads a productive, phlegm-heavy cough through the Lung, the Spleen, and the accumulation of phlegm-damp, and a practitioner treating that pattern is addressing the same problem a mucolytic acts on, by a different logic and with different tools. The tradition would not give everyone the same remedy for a cough; it would ask whether the phlegm is thin and cold or thick and hot and treat accordingly, and a mucolytic likewise does not fit every chest.
The second is aging. The Kidney in Chinese medicine governs the deep constitutional reserve, Jing, that thins across a lifetime, and the tradition has a long language for supporting the older, more depleted body. A modern reading in which glutathione and mitochondrial function decline with age sits near that idea without being it.
None of this makes NAC or glycine a Chinese herb, and a practitioner would not call either one a Kidney or Lung tonic in any classical sense. The mapping is a way for a reader who thinks in this framework to see roughly where these modern compounds land relative to concepts the tradition has reasoned about for a long time. The evidence for them stands on the studies.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Oral NAC is generally well tolerated, with stomach upset the most common effect
The Cochrane review of mucolytics, which pooled long-term oral NAC trials in chronic bronchitis and COPD, found adverse events were broadly comparable between NAC and placebo, with gastrointestinal effects the most frequently reported. This tolerability profile applies to the oral supplement and is distinct from the inhaled (nebulized) form, which can irritate the airways and provoke bronchospasm in susceptible people, and from the high-dose intravenous antidote used for overdose, where anaphylactoid reactions can occur under medical supervision.Poole et al., Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease (Cochrane review)
An overdose is an emergency, not a supplement question
The hospital use of NAC for acetaminophen overdose is a high-dose medical treatment given under supervision and timed against the poisoning. A daily supplement will not treat an overdose. If you or someone else has taken too much acetaminophen, or any overdose is suspected, call emergency services or a poison center immediately.
The inhaled form and asthma
This page is about NAC taken by mouth. The nebulized, inhaled form of acetylcysteine used in some clinical settings can irritate the airways and provoke bronchospasm, a sudden tightening of the airways, particularly in people with asthma or reactive airways. That caution applies to the inhaled medical product, which is used under supervision, and is separate from the oral supplement.
Stomach upset is the common effect
Taken by mouth, NAC is generally well tolerated, and the effect people notice most is gastrointestinal: nausea, a full or queasy stomach, or looser stools, more likely at higher doses. Taking it with food helps. NAC also has a distinct sulfur smell that some people find off-putting. Glycine at the sleep dose is usually easy on the stomach; the larger gram-scale doses used in the GlyNAC protocol can cause loose stools in some people.
Medicines and bleeding to raise with a clinician
NAC may add to the effect of blood-thinning medicines and of drugs that lower blood pressure, and it is sometimes paused before surgery for that reason. If you take an anticoagulant, a nitrate, or blood-pressure medication, or you have surgery coming up, tell the clinician managing you that you take it. This matters most at the higher, gram-scale doses of the combination protocol.
The combination protocol belongs with a clinician
The GlyNAC doses used in the trials are several grams a day of each amino acid, weighed to body weight, and the evidence behind them is small and still awaiting independent replication. Doing this well means a clinician who can check it against your other medicines and watch your response.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
Is NAC proven for anything?
Yes, clearly, for acetaminophen overdose. Given in hospital and in time, NAC is the established antidote and prevents most of the serious liver injury a large dose would otherwise cause, which is why every emergency department stocks it. Beyond that emergency use, the firm ground is narrower: as a mucolytic it modestly reduces flare-ups in COPD, and it has moderate evidence in a few psychiatric conditions. The longevity uses are the newest and the least settled.
What is GlyNAC, and does it slow aging?
GlyNAC is glycine and N-acetylcysteine taken together, the two amino acids the body needs to rebuild glutathione, its main internal antioxidant, which tends to fall with age. In trials from one research group, older adults taking GlyNAC restored their glutathione and improved mitochondrial function, oxidative stress and several aging markers, including in a 16-week randomized trial. Those results are promising. They come from small trials, several with no control group, so whether GlyNAC slows aging in the way the headlines suggest waits on larger independent replication.
Can glycine help me sleep?
The small trials that exist point that way. Around 3 g of glycine before bed helped people fall asleep somewhat faster and feel less groggy the next day. The effect is gentle and the evidence is preliminary, resting on a few small studies, so it is reasonable to try. Steadier sleep habits and the better-studied options carry more weight.
Is NAC safe to take every day?
For most people taking it by mouth, NAC is generally well tolerated at supplement doses. The common effect is stomach upset, more likely at higher doses and eased by taking it with food. Raise these with a clinician first: blood-thinning and blood-pressure medicines, any planned surgery, and asthma if an inhaled form is ever proposed. The high-dose combination protocol, and any use for a specific condition, is a decision to make with a clinician.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 13 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.